Objective: The accurate measurement of reintervention after endovascular aneurysm repair (EVAR) is critical during postoperative surveillance. The purpose of this study was to compare reintervention rates after EVAR from three different data sources: the Vascular Quality Initiative (VQI) alone, VQI linked to Medicare claims (VQI-Medicare), and a "gold standard" of clinical chart review supplemented with telephone interviews.
More than 30,000 patients undergo elective endovascular aneurysm repair (EVAR) in the United States each year. 1 Late results from early randomized trials and Cochrane reviews suggest that 20% to 30% of patients need one or more additional interventions after their initial endovascular repair, [2] [3] [4] and this need for reintervention does not appear to plateau over time. 2, 5 These findings indicate that the number of reinterventions after elective EVAR will likely continue to rise, highlighting the need for diligent postoperative surveillance. As such, it is imperative to develop reliable and scalable means of tracking patients who have undergone EVAR and to follow their long-term outcomes.
However, the current method of follow-updrelying on patients and surgeons to achieve this goaldhas demonstrated limitations. Current reports suggest that nearly one in three patients undergoing EVAR is lost to followup within the first 3 years. [6] [7] [8] [9] Combining data from vascular registries, such as the Vascular Quality Initiative (VQI), 10 with Medicare claims 11 may offer a solution to this challenging problem. The VQI registry was created to allow surgeons to follow procedure-specific outcomes and to provide clinically relevant information to patients and physicians about their vascular care. However, the VQI registry is designed to capture only 1-year outcomesdnot long enough to provide adequate surveillance after EVARdand follow-up continues to be challenging for many surgical practices. 9 Conversely, Medicare claims data offer the advantage of long-term follow-up for a large number of patients and can identify procedures performed at different institutions. However, it can be difficult to accurately identify patients and clinical events using the diagnostic and procedural codes implemented for billing. Furthermore, the number and type of billing codes used to identify events have an impact on the accuracy of event detection 12 and have major implications for the interpretation of study findings.
We hypothesized that VQI data linked to Medicare claims could provide an accurate means by which to assess outcomes in patients undergoing EVAR. To test this hypothesis, we compared the rate of reintervention found within a combined data set of VQI registry data linked to Medicare claims (VQI-Medicare) against the rate found on retrospective chart review at our institution.
METHODS
Cohort creation. We identified all patients who underwent EVAR at our institution from January 2003 to December 2013 using the VQI registry. 10 This method has been shown on internal review to capture 98% to 100% of EVAR procedures performed at our institution (unpublished data). We then performed chart reviews of all patients to identify reintervention events. All reinterventions were adjudicated by two reviewers (J.A.C., P.P.G.). We then obtained the corresponding Medicare claims information for patients who were Medicare eligible. Medicare follow-up data were available from January 2003 to December 2013. Patients identified by the VQI registry were then linked to their respective Medicare claims file. We linked patients using an indirect matching method described previously. 5 Briefly, patients in the VQI registry were identified in Medicare claims data using a series of nonunique identifiers (eg, procedure date, date of birth, ZIP code) to create unique patientlevel matches between the registry and the Medicare claims file.
We then created a cohort of patients for whom followup information was available in all three data sources (VQI registry alone, VQI-Medicare, and chart review). This allowed us to capture the date and type of all procedures performed after the index procedure (EVAR). From this, we were able to assess the concordance of reintervention rates after EVAR between the three different data sources. When data sets were discordant, we conducted telephone interviews with patients to assess whether a reintervention had occurred.
Primary outcomes. Our primary outcome measure was reintervention after EVAR. We defined reintervention as any additional procedure performed after the index hospitalization to treat endoleaks, further aneurysmal degeneration, or any complications related to the original repair (eg, femoral artery repair for access site complication). Any subsequent procedures performed for pre-existing conditions (eg, for an endovascular repair of a popliteal artery aneurysm) were not included as reinterventions. We compared the rate of reintervention between VQI-Medicare and chart review at 1 year, 2 years, and 3 years using Kaplan-Meier estimation. We assessed the concordance of reintervention rates using Cohen's k.
Medicare coding algorithm. We created a list of primary diagnosis and procedure codes using the International Classification of Diseases, Ninth Revision (ICD-9) to identify reintervention events. The initial list of codes compiled was based on prior work at our institution and others (Supplementary Table I , online only). 5, 6, 13 Medicare billing code events identified within the VQIMedicare linked data set were then compared with the reintervention events identified on chart review to determine whether billing events represented true reinterventions. If the occurrence of a reintervention was unclear, telephone interviews of the patients were conducted. We then calculated the accuracy of each individual billing code by determining the percentage of billing events representing a true clinical event (eg, a specific billing code appearing 10 times but representing a true reintervention of only four times would have 40% accuracy). We determined the accuracy for all codes appearing in the first year after EVAR. If a billing code was associated with a true clinical event <50% of the time, it was considered for removal from our list of codes used to represent reintervention. Details of the revisions to the coding algorithm are described in the Supplementary Methods (online only) and Supplementary Table II (online only).
ARTICLE HIGHLIGHTS
Statistical analysis. We report absolute numbers and percentages where appropriate. Continuous variables are represented as means with standard deviations, and categorical variables are listed as percentages. The final cohort for analysis represents the same group of patients, differing only by the data source from which reintervention events are identified; therefore, no comparative statistics on baseline characteristics were calculated. Rates of reintervention were calculated using Kaplan-Meier survival analysis with hazard function estimation. In addition, because the cohorts compared represent the same patients and differ only in which data source was used to assess the rate of reintervention, the at-risk number at each time point is the same for the data sets being compared. Concordance between the reintervention rates obtained from the three data sets was analyzed using Cohen's k. We also calculated the sensitivity and specificity of VQI-Medicare linked data to identify a reintervention event compared with chart review. All statistical analyses were performed using Stata version 14 software (StataCorp LP, College Station, Tex).
Human subjects protection. Medical record review and patient interviews for this study were approved by the Committee for the Protection of Human Subjects at Dartmouth College. All patients' personal health information was protected, records and outcomes were deidentified, and no testing or procedures were required for this study. Thus, the need for specific consent was waived. VQI and Medicare information is collected under the auspices of an Agency for Healthcare Research and Quality-designated Patient Safety Organization. Therefore, this portion of the study was exempt from internal review.
RESULTS
Details of the analytic cohort. We identified 729 patients who underwent EVAR at our institution during the study period. We excluded 68 patients (9%) who did not have VQI follow-up available and 114 patients (16%) for whom Medicare claims data were not available (71 patients <65 years of age, 43 not matched to their respective Medicare claims file).
All (100%) of the remaining 547 patients had follow-up information available from each of the three data sources. This group of patients formed the final analytic cohort that was used to compare rates of reintervention and to examine concordance between our data sources. Cohort characteristics were typical for this population of patients (Table I) , with a mean age of 75.5 years and 22.9% being female. Hypertension and smoking history were common, and most patients were receiving preoperative aspirin and statin therapy. More than 90% of EVARs were performed on an elective basis.
Rates of reintervention. The Kaplan-Meier estimated 1-year rate of reintervention after EVAR using the VQI registry alone was 3%, corresponding to a total of 12 events. As the VQI is designed to collect 1-year outcomes, we truncated survival estimates using the VQI registry alone at this time point. The estimated rate of reintervention found on chart review was twice that found using the VQI registry alone, showing a 1-year reintervention rate of 6% or 30 events. The chart review rate of reintervention maintained a nearly linear increase during the study period and was 16% at 3 years.
The rate of reintervention found using VQI-Medicare was 6% at 1 year and 18% at 3 years. This rate was calculated using a coding algorithm composed of the codes outlined in Table II .
Concordance between the data sets. Using the VQI registry alone, 12 reintervention events were identified within the first year after EVAR. Chart review confirmed these 12 events and identified an additional 18 events not captured by the VQI registry. The additional events found by chart review but not identified using the VQI registry consisted of EVAR limb thrombectomy or repair of a kinked EVAR limb (n ¼ 4), femoral artery reconstruction or femoral-femoral bypass for an occluded EVAR limb (n ¼ 4), unsuccessful reintervention procedures (n ¼ 3), proximal aortic cuff placement (n ¼ 3), coiling for type II endoleak (n ¼ 1), and patients who died at another hospital and were thought to have suffered an aneurysm-related mortality event (n ¼ 3). Full details of the reintervention procedures are described in Supplementary Table III (online only) . Both the baseline and revised coding algorithms of VQI-Medicare linked data captured all 30 of the events found on chart review during the first year. However, the baseline coding algorithm identified 35 additional events within the first year that did not represent a true reintervention. Changes were made in the coding algorithm to generate our revised coding algorithm as detailed in the Methods and Supplementary Methods (online only). These changes improved the concordance between chart review and VQI-Medicare significantly, with the revised coding algorithm now identifying only four events within the first year that did not represent a true reintervention based on chart review and telephone interview of the patients. The statistical agreement between chart review and VQI-Medicare before the coding changes was 0.63 at both 1 year and 3 years, as determined by Cohen's k. However, after changes to the coding algorithm, this improved to 0.93 and 0.80 at 1 year and 3 years, respectively, indicating excellent agreement. Using chart review as the "gold standard," the sensitivity of VQI-Medicare to identify a reintervention event remained stable at 91.9% and specificity improved from 86.7% to 96.1% at 3 years (Fig) .
DISCUSSION
Our review of a single-center series using multiple data sources to evaluate reintervention after EVAR demonstrated two important findings. First, nearly one in five patients whose abdominal aortic aneurysm is treated by endovascular means can expect to undergo reintervention, and this need for reintervention does not plateau over time. Second, our study suggests that a 2 we also found that the rate of reintervention in our cohort was highly dependent on the codes chosen to represent events from the Medicare claims data. Initially, our coding algorithm was highly sensitive but had poor specificity, greatly overestimating the true reintervention event rate. For example, our initial list of codes used for event detection in Medicare included ICD-9 code 3893, "venous catheterization not elsewhere classified." We included this code because we hypothesized that it would be associated with transcaval coil embolization, a common method of treating type II endoleaks at our institution. This billing code appeared 21 times in our institution's Medicare data. However, it was associated with a reintervention found on chart review in only 1 of 21 cases, and in this case, it was also associated with another ICD-9 code used for event detection. We therefore removed ICD-9 code 3893 from our list of codes used to represent reintervention events. By performing adjudications of billing codes such as this, we were able to modify our coding algorithm such that the specificity of reintervention events found using the VQIMedicare database improved from 86.7% to 96.1% at 3 years while maintaining high sensitivity (91.9% at 3 years). Similarly, the concordance of reintervention rates found using chart review vs the VQI-Medicare database was high (0.93 and 0.80 at 1 year and 3 years, respectively) after coding algorithm revision. Challenges with coding accuracy at both the billing code entry 14 and research use levels 12, 15, 16 have been described by many investigators across specialties. Even within vascular surgery, coding algorithms to define clinical events such as stroke can be difficult to define 15, 17 and may have a profound impact on study results. These findings in concert with ours highlight the need for researchers to carefully select codes to represent true events when using Medicare data and to perform chart-level adjudication of billing codes to ensure accuracy.
We noted a substantial difference in the number of events detected by the VQI data set alone and those found on chart review. These events most often represented complications related to EVAR, such as EVAR limb thrombectomy or femoral artery reconstruction for access site complications. These procedures may have been errors in data entry (EVAR limb thrombectomy) or have been overlooked as related to the index EVAR (femoral artery reconstruction). These events represent opportunities for improvement for data entry into VQI in considering postoperative surveillance for EVAR.
Our findings have important implications. First, the cumulative incidence of reintervention after EVAR demonstrates a linear increase over time. This finding is consistent with long-term results from randomized trials 2 and may account for the inferior outcomes associated with patients who are lost to follow-up. 8 Furthermore, this indicates that patients who undergo EVAR must have long-term surveillance as the rate of reintervention does not appear to plateau. The method described in our report, which leverages registry data and Medicare claims, may be a cost-effective approach for a distributed surveillance network to evaluate EVAR performance over time. This linked registry-claims surveillance system is both sensitive and specific. It also offers a scalable mechanism that can identify reintervention events occurring at either the index or outside institutions for Medicare patients. Finally, it offers a reliable method to monitor mortality from rupture, even after EVAR, across the United States. These attributes of the linked registry represent an important advance over VQI data taken in isolation. Our study has limitations. It is an experience from a single center, and as such, Medicare coding trends from our institution may not be representative of those at other hospitals. This limitation highlights the need for a multicenter validation project, which we are currently undertaking. Medicare coding events were compared with retrospective chart review. The optimal comparison would be prospectively collected data with blinded evaluation of reintervention events. However, no such source is available for use with the VQI registry. Therefore, we thought that our two-reviewer retrospective method of event adjudication provided the most reliable information possible. Our cohort was limited to patients who were found in all three data sources, and because of this, we cannot comment on coding trends for patients who are not Medicare eligible. We adjudicated chart review events against billing codes during the first year, using our findings to revise our coding algorithm. We then applied these changes to the 3 years of data. We did not think that it was necessary to adjudicate all 3 years of events for a series of reasons. First, our k concordance remained excellent (>0.8) for all years analyzed. Second, the sensitivity and specificity of VQI-Medicare compared with chart review were 92% and 96%, respectively. Finally, our findings closely resembled those of randomized clinical trials. Although our sensitivity and specificity remained excellent (92% and 96%, respectively), we were not able to obtain perfect 100% agreement. However, given the known limitations of claims data, perfect agreement is likely not possible.
CONCLUSIONS
VQI data linked to Medicare claims closely mirrored chart review in evaluating reintervention after EVAR, and the rates of reintervention we found were similar to those published in randomized clinical trials.
Furthermore, VQI-Medicare was 92% sensitive and 96% specific in identifying a true reintervention event. The rate of events found in Medicare claims was highly dependent on the billing codes chosen to represent those events. Only after close adjudication and iterative revisions of our coding algorithm did rates become similar, highlighting the care that must be taken in using Medicare data for clinical research. Nevertheless, VQIMedicare represents a validated and accurate assessment of reintervention after EVAR, without the need for labor-intensive chart review. 
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Coding algorithm. Our initial coding algorithm to define reintervention events after endovascular aneurysm repair included 42 International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes and 24 ICD-9 procedure codes (Supplementary Table I , online only). We defined a reintervention event in Medicare claims as any patient having one of these billing codes appear in their Medicare claims file after their index procedure. We allowed either an ICD-9 diagnosis code (which was the primary diagnosis code for the admission) or an ICD-9 procedure code to represent a reintervention event. These were not considered mutually exclusive, so that an ICD-9 primary diagnosis code also found with an ICD-9 procedure code during the same admission was considered a single reintervention event. Although it included subcodes that were not specific to vascular procedures, we thought it important to initially include procedure code 9966.x to capture potentially miscoded events. Code 9957 was included for a similar reason.
Using the original coding algorithm, the Vascular Quality Initiative (VQI)-Medicare linked data identified 65 events during the first year after endovascular aneurysm repair (Supplementary Table III , online only). We then compared the VQI-Medicare identified events with the reintervention events found on chart review. We conducted telephone interviews if the clinical outcome could not be adequately determined on chart review. If a patient died during a hospital admission at another institution and that admission was connected with one of the billing codes in our algorithm, we assumed that the death was aneurysm related and associated with an attempted reintervention. This was done to provide the most conservative estimate of events. Although we considered records from all hospitals that had been entered into the patient's available medical record, we did not visit outside institutions to perform additional chart reviews. We did not attempt telephone interviews to assess for reintervention events in deceased patients.
Billing codes with an accuracy lower than 50% were considered for removal from the coding algorithm (Supplementary Table II , online only). For example, procedure code 3893 was associated with a true clinical reintervention event in 1 of 21 cases; this code was therefore removed from our list of codes chosen to represent a reintervention event. If a code appeared only once, however, we did not think that this provided adequate information to remove it from the algorithm. Therefore, codes appearing only once, even if not associated with a clinical event, were kept in the algorithm. We also removed codes with 50% accuracy that were associated with another code that consistently performed well. For example, diagnosis code 44422 was associated with a true reintervention event in one of two cases. However, that reintervention event was also associated with procedure code 3929, a code that was associated with a true event in five of five cases. We therefore removed diagnosis code 44422 from the coding algorithm. The rate of reintervention using the VQI-Medicare data was then recalculated using the revised list of billing codes.
